Table 1.

Plasma levels of inflammatory mediators are equivalent following CBDL and LPS challenge

Inflammatory Mediator	C57BL/6	LBPKO
TNF-α	6,966±1,901	6,084±1,500
IL-6	88,920±18,150	72,320±10,660
MIP-2	54,050±11,510	44,570±8,984
MCP-1	25,860±7,053	22,210±4,131
IL-1β	5,372±1,091	6,861±757.5
IL-4	33,630±4,572	24,920±2,846
IL-10	28,910±4,897	20,700±4,031
IL-18	5,980±1,075	4,680±654.4
Eotaxin	12,570±2,352	8,696±993.
IL-1ra	11,560±2,240	11,750±1,404
IL-5	1,558±366.9	8,424±7,046
IL-12	5,641±809.3	4,791±705.9
IFN-γ	7,827±1,318	7,850±1,171
MIP-1α	26,260±4,486	21,860±3,052
TNFSR1	7,407±1,737	4,116±475.4
TNFSR2	6,258±975.4	5,404±1,336
IL-2	8,947±1,560	7,150±781.3
IL-13	48,010±14,190	27,790±6,042
RANTES	1,302±208.0	1,882±587.7
Lix	10,240±1,460	8,251±430.3

Data are expressed as means ± SE, in pg/ml. CBDL, common bile duct ligation; LBPKO, LPS-binding protein-deficient mice. P > 0.05 for all mediators.